… Serum samples from SARS patients Two panels of serum samples from the recovered
SARS patients were used in this study. The first panel of 35 samples were leftover from the …

… , recovered subjects exhibited robust cTFH responses to the SARS-CoV-2 spike protein, with
a median of 0.92% spike-… cross-reactive antibodies recovered from convalescent patients to …

… the dynamics of SARS-CoV-2 antibodies, including anti-spike protein 1 (S1) … SARS-CoV-2
over time in a cohort of patients who were previously infected with the wild-type SARS-CoV-2. …

… the acute period of SARS (10). In the present study, we focused on anti-SARS-CoV immunity
in patients who had recovered from SARS but not in patients suffering acutely from SARS or …

… (N-) proteins may define COVID-19 severity. Therefore, we compare the SARS-CoV-2-reactive
T cell responses in moderate, severe, and critical COVID-19 patients and unexposed …

… We found that the SARS-CoV-2 RBD contained four ID sites, IDd, IDe, IDf, … SARS-CoV-2
Spike protein shares 75.96% amino acid sequence identity with that of the SARS-CoV, we found …

… We also measured the binding antibodies to the different domains (RBD, S1, and S2) of
SARS-CoV-2 spike protein in the plasma of these six patients. The kinetics of NAbs (right Y axis) …

… findings of 1,850 patients to describe the dynamic changes of the total antibody, spike protein
(S… antibody levels of patients with confirmed SARS-CoV-2 infection and found that 39.6% of …

… In almost 90% of patients, we detected a large number … SARS-CoV-2 spike protein [5]. The
course of sign and symptom resolution in cases with moderate or severe disease who recover …

… of patients, SARS-CoV-2 specific IgM and IgA levels decreased substantially to background
levels within 1 year. Spike-… antibodies against the SARS-CoV-2 RBD spike protein in plasma …